• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL REVIVE - THROMBECTOMY DEVICE; EMBOLECTOMY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL REVIVE - THROMBECTOMY DEVICE; EMBOLECTOMY CATHETER Back to Search Results
Catalog Number FRS21452299
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Paralysis (1997)
Event Date 01/10/2017
Event Type  Injury  
Manufacturer Narrative
This initial mdr is the only report being submitted for mfr report #2954740-2017-00217.Udi: (b)(4).Concomitant medical products: guiding catheter (9fr optimo, tokai medical product), microcatheter (marksman), penumbra 0.074inch, medico's hirata, trevo.(b)(4).The product will not be returned for analysis however a device history record review is currently being conducted and the results are not yet available.Additional information will be submitted within 30 days of receipt.
 
Event Description
It was reported by a healthcare professional that, as part of the (b)(6) study, a revive se (frs21452299 / s10776) was used on patient number 206-04 during a thrombectomy procedure where hemiplegia was observed post procedure at the upper right lower limb due to hyperfusion phenomenon.On (b)(6) 2017 at 6:30am, acute stage cerebral infarction developed with internal carotid artery system left extracranial internal carotid artery occlusion.The patient was hospitalized at 8:18am.Prior to the procedure, nihss: 19 points, aspects-ct: 8 points, aspects-dwi: 7 points, tici: 0 points.There was almost no tortuousness at the occlusion site and no stenosis to the proximal portion was observed.The vessel diameter and length of the occlusion site were unknown.It was believed that it was a wake up stroke, therefore t-pa was not administered.The puncture time was 9:19am.A guiding catheter (9fr optimo, tokai medical product) was inserted at 9:30am, a microcatheter (marksman) was inserted at 10:15am, and a catheter for thrombus removal (penumbra 0.074inch, medico's hirata) were also used during this procedure.Prior to deployment, mrs: 0.The revive se was deployed three times at the lesion and tici:2a was obtained at 10:20am.Another thrombectomy device (trevo) was deployed once and tici: 2a was obtained at 10:46am.At last, carotid artery stenting (cas) was performed and tici: 2b was obtained at 11:47am and the procedure was completed.The guiding system was removed at 11:54am.Approximately 4 hours after the procedure, hemiplegia was observed at the upper right lower limb due to hyperfusion phenomenon.The patient was sedated, so nihss was not performed.On (b)(6) 2017, it was confirmed that the symptoms of paralysis had resolved.On (b)(6) 2017, aspects-dwi: 6 points.On (b)(6) 2017, nihss: 2 points.On (b)(6) 2017, mrs: 1.In the physician's assessment, the revive se was not the cause of the event; the cerebral hyperfusion phenomenon was considered to be caused by cas.
 
Manufacturer Narrative
This final mdr is the only report being submitted for mfr report #2954740-2017-00217.The revive se was not returned for investigation.A review of the manufacturing documentation associated with this lot presented no issues during the manufacturing or inspection process that can be related to the reported complaint.Device ineffective and hemiplegia are known potential adverse events associated with use of the revive se device and are listed in the product ifu.All products undergo a 100% inspection prior to being released for sale; there is no evidence of a manufacturing issue related to this complaint.Review of the information suggests that restoration of blood flow in the target lesion area and thrombus conformation may have contributed to the reported events.There is no current safety signal identified related to the reported event(s) based on review of complaint history for the device.No further actions are required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVIVE - THROMBECTOMY DEVICE
Type of Device
EMBOLECTOMY CATHETER
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel
SZ 
Manufacturer Contact
karen anigbo
821 fox lane
san jose, CA 95131
5088288374
MDR Report Key6740532
MDR Text Key80924856
Report Number2954740-2017-00217
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00878528000006
UDI-Public(01)00878528000006(17)190430(10)S10776
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 06/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2019
Device Catalogue NumberFRS21452299
Device Lot NumberS10776
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/30/2017
Initial Date FDA Received07/25/2017
Supplement Dates Manufacturer Received09/15/2017
Supplement Dates FDA Received09/15/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/25/2016
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient Weight74
-
-